5Kantor PF, Lucien A, Kozak R,et al. The antianginal drug trimetazidine shifts cardic energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long chain 3 - kctoacyl coenzyme A thiolase[ J]. Cire Res ,2000,86(5 ) :580.
6李焕德,卢安瑛,刘世坤.临床实用新药[M].第13版.北京:人民卫生出版社,2006.271.
二级参考文献5
1Boddeke E,Hugtenburg J, Jap W, et al. New anti-ischaemic drugs;cytoprotective action with no primary haemodynamic effects. Trends Pharm Sci,1989,10(6) :397-400
2Lavancy N, Martin J, Rossi A. Anti-isohaemic effects of trimetazidine. 31 P-NMR spectroscopy in the isolated rat heart. Arch Intern Pharmacodyn Ther, 1987,286( 1 ) :97-110
3Detry JM,Sellier P, Pennaforte S,et al. Trimetazidine: a new concept in the treatment of angina:comparison with propranolol in patients with stable angina. Trimetazidine European Multicenter Study Group. Br J Clin Pharmacol, 1994,37 (4) :279-288
4Detry JM, Leclercq PJ. Trimetazidine European Multicenter Study versus propranolol in stable angina pectoris: contribution of Holter electrocardiographic ambulatory monitoring. Am J Cardiol, 1995,76(1) :8B-11B
5Dalla-Volta S, Maraglino G, Della-Valentina P, et al. Comparison of trimetazidine with nifedipine in effort angina:a double-blind, crossover study. Cardiovasc Drugs Ther, 1990,4 ( Suppl 4 ): 853-859
